Publication:
Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature

dc.contributor.authorTeruel, María
dc.contributor.authorBarturen, Guillermo
dc.contributor.authorMartínez-Bueno, Manuel
dc.contributor.authorCastellini-Pérez, Olivia
dc.contributor.authorBarroso-Gil, Miguel
dc.contributor.authorPovedano, Elena
dc.contributor.authorKerick, Martin
dc.contributor.authorCatalà-Moll, Francesc
dc.contributor.authorMakowska, Zuzanna
dc.contributor.authorButtgereit, Anne
dc.contributor.authorPers, Jacques-Olivier
dc.contributor.authorMarañón, Concepción
dc.contributor.authorBallestar, Esteban
dc.contributor.authorMartin, Javier
dc.contributor.authorCarnero-Montoro, Elena
dc.contributor.authorAlarcón-Riquelme, Marta E.
dc.contributor.authoraffiliation[Teruel,M; Barturen,G; Martínez-Bueno,M; Castellini-Pérez,O; Barroso-Gil,M; Povedano,E; Marañón,C; Carnero-Montoro,E; Alarcón-Riquelme,ME] GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain. [Kerick,M; Martin,J] IPBLN-CSIC, Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científcas, Granada, Spain. [Català-Moll,F; Ballestar,E] Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), Badalona, Barcelona, Spain. [Català-Moll,F; Ballestar,E] IDIBELL, Bellvitge Biomedical Research Institute L’Hospitalet de Llobregat, Barcelona, Spain. [Makowska,Z; Buttgereit,A] Pharmaceuticals Division, Bayer Pharma Aktiengesellschaft, Berlin, Germany. [Pers,JO] Université de Brest, INSERM, Labex IGO, CHU de Brest, Brest, France.[Alarcón-Riquelme,ME] Institute for Environmental Medicine, Karolinska Institutet, Solna, Sweden.
dc.contributor.funderFunding for the preparation of this manuscript has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement nº 115,565, resources composed of the financial contribution from the European Union's Seventh Framework Program (FP7/2007-2013) and the EFPIA companies’ in kind contribution. MT is supported by a Spanish grant from Health Department, Junta de Andalucía (PI/0017/2016) and through the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 806975. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. EC-M was funded by the Postdoctoral Training Subprogramme Juan de la Cierva-Ministry of Economy and Competitiveness (FJCI_2014_20652). We thank Ralf Lesche for the production of RNASeq data and Marc Torres Ciuró for design support.
dc.contributor.groupPRECISESADS Clinical Consortiumes_ES
dc.contributor.groupPRECISESADS Flow Cytometry Study Groupes_ES
dc.date.accessioned2023-01-10T11:20:41Z
dc.date.available2023-01-10T11:20:41Z
dc.date.issued2021-12-02
dc.description.abstractPrimary Sjögren’s syndrome (SS) is a systemic autoimmune disease characterized by lymphocytic infiltration and damage of exocrine salivary and lacrimal glands. The etiology of SS is complex with environmental triggers and genetic factors involved. By conducting an integrated multi-omics study, we confirmed a vast coordinated hypomethylation and overexpression effects in IFN-related genes, what is known as the IFN signature. Stratified and conditional analyses suggest a strong interaction between SS-associated HLA genetic variation and the presence of Anti-Ro/SSA autoantibodies in driving the IFN epigenetic signature and determining SS. We report a novel epigenetic signature characterized by increased DNA methylation levels in a large number of genes enriched in pathways such as collagen metabolism and extracellular matrix organization. We identified potential new genetic variants associated with SS that might mediate their risk by altering DNA methylation or gene expression patterns, as well as disease-interacting genetic variants that exhibit regulatory function only in the SS population. Our study sheds new light on the interaction between genetics, autoantibody profiles, DNA methylation and gene expression in SS, and contributes to elucidate the genetic architecture of gene regulation in an autoimmune population.es_ES
dc.description.versionYeses_ES
dc.identifier.citationTeruel M, Barturen G, Martínez-Bueno M, Castellini-Pérez O, Barroso-Gil M, Povedano E, Kerick M, et al. Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature. Sci Rep. 2021 Dec 2;11(1):23292es_ES
dc.identifier.doi10.1038/s41598-021-01324-0es_ES
dc.identifier.essn2045-2322
dc.identifier.pmcPMC8640069
dc.identifier.pmid34857786es_ES
dc.identifier.urihttp://hdl.handle.net/10668/4558
dc.journal.titleScientific Reports
dc.language.isoen
dc.page.number18 p.
dc.publisherSpringer Naturees_ES
dc.relation.publisherversionhttps://www.nature.com/articles/s41598-021-01324-0es_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.accessRightsAcceso abiertoes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectAutoantibodieses_ES
dc.subjectEpigenetices_ES
dc.subjectAutoimmune diseaseses_ES
dc.subjectGene expressiones_ES
dc.subjectSjogren's syndromees_ES
dc.subjectGenetic variationes_ES
dc.subjectAutoanticuerposes_ES
dc.subjectEpigenómicaes_ES
dc.subjectEnfermedades autoinmuneses_ES
dc.subjectExpresión génicaes_ES
dc.subjectSíndrome de Sjögrenes_ES
dc.subjectVariación genéticaes_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Chemical Phenomena::Biochemical Phenomena::Biochemical Processes::DNA Methylationes_ES
dc.subject.meshMedical Subject Headings::Check Tags::Femalees_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expressiones_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expression Regulationes_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Biological Factors::Antigens::Antigens, Surface::Histocompatibility Antigens::HLA Antigenses_ES
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Peptides::Intercellular Signaling Peptides and Proteins::Interferonses_ES
dc.subject.meshMedical Subject Headings::Check Tags::Malees_ES
dc.subject.meshMedical Subject Headings::Diseases::Immune System Diseases::Autoimmune Diseases::Arthritis, Rheumatoid::Sjogren's Syndromees_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodieses_ES
dc.subject.meshMedical Subject Headings::Disciplines and Occupations::Natural Science Disciplines::Biological Science Disciplines::Biology::Genetics::Genomics::Epigenomicses_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Variationes_ES
dc.subject.meshMedical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Processes::Gene Expression Regulation::Epigenesis, Genetices_ES
dc.subject.meshMedical Subject Headings::Diseases::Immune System Diseases::Autoimmune Diseaseses_ES
dc.titleIntegrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signaturees_ES
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 5 of 24
Loading...
Thumbnail Image
Name:
Teruel_IntegrativeEpigenomics.pdf
Size:
3.81 MB
Format:
Adobe Portable Document Format
Description:
Artículo publicado
No Thumbnail Available
Name:
Teruel_IntegrativeEpigenomics_MaterialSuplementario_1.docx
Size:
11.9 KB
Format:
Microsoft Word XML
Description:
Material suplementario
No Thumbnail Available
Name:
Teruel_IntegrativeEpigenomics_MaterialSuplementario_2.docx
Size:
106.75 KB
Format:
Microsoft Word XML
Description:
Material suplementario
No Thumbnail Available
Name:
Teruel_IntegrativeEpigenomics_MaterialSuplementario_3.docx
Size:
102.27 KB
Format:
Microsoft Word XML
Description:
Material suplementario
Loading...
Thumbnail Image
Name:
Teruel_IntegrativeEpigenomics_MaterialSuplementario_4.pdf
Size:
105.96 KB
Format:
Adobe Portable Document Format
Description:
Material suplementario